Wed Feb 26 21:22:32 UTC 2025: ## Lilly to Invest $27 Billion in US Manufacturing, Creating Thousands of Jobs
**Washington, D.C.** – Pharmaceutical giant Eli Lilly and Company announced plans Wednesday to invest at least $27 billion in building four new manufacturing plants in the United States over the next five years. This expansion is expected to generate over 3,000 skilled jobs for engineers, scientists, and other specialists, along with an additional 10,000 construction jobs.
The announcement follows a recent meeting between President Trump and pharmaceutical CEOs, where concerns about potential tariffs on imported drugs were discussed. Commerce Secretary Howard Lutnick praised Lilly’s decision, stating it aligns with the President’s goals to boost domestic manufacturing. Lilly CEO David Ricks expressed hope for government exemptions on medical supply tariffs and continued tax reforms, citing previous tax cuts as instrumental to the company’s investment.
Three of the new facilities will focus on producing pharmaceutical raw materials, while the fourth will manufacture injectable medications. Specific plant locations will be announced later this year. This investment adds to Lilly’s existing $23 billion commitment to US manufacturing since 2020, bringing the total investment to over $50 billion. The move comes amidst broader industry trends, with Apple recently announcing a $500 billion US investment plan.
The announcement also touches upon concerns regarding potential FDA staff reductions. Ricks noted that Lilly’s fees contribute to FDA staffing and expressed concern about potential redirection of these funds. President Trump’s administration has been pressing pharmaceutical companies to increase domestic production, and the possibility of a 25% tariff on imported pharmaceuticals remains a factor. While a potential exemption for medical supplies has been discussed, no official decision has been made.
First Piper 